Uncategorized
Avedro Receives FDA Approval for Photrexa® Viscous, Photrexa® and the KXL® System for Corneal Cross-Linking
WALTHAM, Mass.--(BUSINESS WIRE)--Avedro receives FDA approval for its corneal cross-linking product. The product is a first-in-class therapeutic treatment for progressive keratoconus, which is a sight threatening indication.
